Lyon Ra

795 total citations
20 papers, 577 citations indexed

About

Lyon Ra is a scholar working on Geriatrics and Gerontology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lyon Ra has authored 20 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 5 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lyon Ra's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Health Sciences Research and Education (3 papers) and Receptor Mechanisms and Signaling (3 papers). Lyon Ra is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Health Sciences Research and Education (3 papers) and Receptor Mechanisms and Signaling (3 papers). Lyon Ra collaborates with scholars based in United States and United Kingdom. Lyon Ra's co-authors include Milt Titeler, Richard A. Glennon, A K Haque, David M. Asmuth, Gail L. Woods, K.R. Gogas, S.D. Glick, Robert C. Young, Michael E. Parsons and M. Edward Pierson and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lyon Ra

18 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyon Ra United States 9 373 226 152 60 47 20 577
Marion E. Wolf United States 17 201 0.5× 211 0.9× 121 0.8× 70 1.2× 134 2.9× 60 814
Barbara A. Bennett United States 14 372 1.0× 214 0.9× 50 0.3× 28 0.5× 79 1.7× 32 655
Kimihiko Goto Japan 14 182 0.5× 171 0.8× 57 0.4× 16 0.3× 49 1.0× 40 743
William D. Wessinger United States 16 409 1.1× 280 1.2× 50 0.3× 13 0.2× 95 2.0× 45 816
Stephen Espitia United States 12 248 0.7× 239 1.1× 56 0.4× 173 2.9× 96 2.0× 17 703
Liliane Unger Germany 16 251 0.7× 255 1.1× 40 0.3× 92 1.5× 167 3.6× 24 616
Antonella Bacosi Italy 13 105 0.3× 116 0.5× 63 0.4× 22 0.4× 139 3.0× 21 662
F. M. Berger United States 15 89 0.2× 96 0.4× 41 0.3× 61 1.0× 60 1.3× 69 661
David J. McCann United States 16 352 0.9× 349 1.5× 27 0.2× 22 0.4× 24 0.5× 26 698
Philip J. Fowler Sweden 12 257 0.7× 203 0.9× 17 0.1× 55 0.9× 98 2.1× 24 590

Countries citing papers authored by Lyon Ra

Since Specialization
Citations

This map shows the geographic impact of Lyon Ra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyon Ra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyon Ra more than expected).

Fields of papers citing papers by Lyon Ra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyon Ra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyon Ra. The network helps show where Lyon Ra may publish in the future.

Co-authorship network of co-authors of Lyon Ra

This figure shows the co-authorship network connecting the top 25 collaborators of Lyon Ra. A scholar is included among the top collaborators of Lyon Ra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyon Ra. Lyon Ra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ling, Hua, et al.. (2016). Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction. Vascular Health and Risk Management. 12. 163–163. 13 indexed citations
2.
McCormack, J. G., et al.. (2008). The effects of different analgesic regimens on transcutaneous CO 2 after major surgery. Anaesthesia. 63(8). 814–821. 10 indexed citations
3.
Ra, Lyon, et al.. (2004). Managed Care Market Perspectives on the Over-the-Counter Availability of Statins. Journal of Managed Care Pharmacy. 10(6). 543–550. 7 indexed citations
4.
Ra, Lyon, A K Haque, David M. Asmuth, & Gail L. Woods. (1996). Changing Patterns of Infections in Patients with AIDS: A Study of 279 Autopsies of Prison Inmates and Nonincarcerated Patients at a University Hospital in Eastern Texas, 1984-1993. Clinical Infectious Diseases. 23(2). 241–247. 26 indexed citations
5.
Shan, Hong, Karl Romstedt, D. R. FELLER, et al.. (1994). A Structure-Activity Relationship Study of Benzylic Modifications of 4-[1-(1-Naphthyl)ethyl]-1H-imidazoles on .alpha.1- and .alpha.2-Adrenergic Receptors. Journal of Medicinal Chemistry. 37(15). 2328–2333. 15 indexed citations
6.
7.
Ra, Lyon, et al.. (1990). Identification and characterization of B2 bradykinin receptors in sheep nasal turbinate membranes. Pulmonary Pharmacology. 3(4). 209–214. 4 indexed citations
8.
Ra, Lyon. (1990). Formulary-control procedures in a staff-model health maintenance organization.. PubMed. 47(2). 340–2. 8 indexed citations
9.
Ra, Lyon. (1990). Formulary-control procedures in a staff-model health maintenance organization. American Journal of Health-System Pharmacy. 47(2). 340–342. 4 indexed citations
10.
Gogas, K.R., Lindsay B. Hough, Lyon Ra, et al.. (1989). A role for histamine and H2-receptors in opioid antinociception.. Journal of Pharmacology and Experimental Therapeutics. 250(2). 476–484. 50 indexed citations
11.
Glennon, Richard A., et al.. (1989). Stimulus properties of arylpiperazines: NAN‐190, a potential 5‐HT1A serotonin antagonist. Drug Development Research. 16(2-4). 335–343. 43 indexed citations
12.
Titeler, Milt, Lyon Ra, & Richard A. Glennon. (1988). Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology. 94(2). 213–6. 289 indexed citations
13.
Ra, Lyon, et al.. (1987). 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.. Molecular Pharmacology. 31(2). 194–199. 91 indexed citations
14.
Ra, Lyon, et al.. (1986). Determining staffing requirements in a community hospital pharmacy department.. PubMed. 21(7). 660–2, 665. 1 indexed citations
15.
16.
Ra, Lyon. (1985). Adverse drug effects: evaluation of four secondary reference sources.. PubMed. 20(3). 315–7, 320. 2 indexed citations
17.
Ra, Lyon. (1984). Use of general (tertiary) reference sources in a university hospital-based drug information service.. PubMed. 19(3). 210–6, 218. 1 indexed citations
18.
Ra, Lyon, et al.. (1983). Effects of a combination of common snack foods on some risk factors in heart disease and diabetes in rats.. Journal of the American College of Nutrition. 2(2). 141–148.
19.
20.
Ra, Lyon, et al.. (1952). Rural clinics for children with heart disease.. PubMed. 48(2). 130–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marion E. Wolf Breakdown of academic impact, for papers by Barbara A. Bennett Breakdown of academic impact, for papers by Kimihiko Goto Breakdown of academic impact, for papers by William D. Wessinger Breakdown of academic impact, for papers by Stephen Espitia Breakdown of academic impact, for papers by Liliane Unger Breakdown of academic impact, for papers by Antonella Bacosi Breakdown of academic impact, for papers by F. M. Berger Breakdown of academic impact, for papers by David J. McCann Breakdown of academic impact, for papers by Philip J. Fowler
Rankless by CCL
2026